1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Drug Discovery Outsourcing Market Report 2022-2032

Drug Discovery Outsourcing Market Report 2022-2032

  • June 2022
  • 355 pages
  • ID: 6285053
  • Format: PDF
  • Visiongain Reports Ltd.

Summary

Table of Contents

Forecasts by Service Type (Chemical Services, Biology Services, Lead Optimisation, Lead Identification & Screening, Others), by Molecule Type (Large Molecule Drugs, Small Molecule Drugs), by Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact Analysis and Recovery Pattern Analysis

The Drug Discovery Outsourcing Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Outsourcing Drug Development Procedures to Benefit the Pharmaceutical Industry

Outsourcing drug development procedures allows scientists to focus on developing and commercialising new and novel methodologies and technologies, as well as other discoveries that could benefit the pharmaceutical industry. Pharmaceutical or biotech companies are looking to obtain significant added value that complements or substitutes internal power, expense, speed and development capabilities. Even small start-up drug research companies sometimes outsource their chemistry from the very beginning of their activities, because their creditors push them to do so, primarily because of cost-effectiveness reasons.

Reduced Pharmaceutical and Biotech R&D Budgets

Pharmaceutical and biotech companies now look to their outsourcing partners to weigh up important strategic and implementation decisions as well. Price, time to market, and risk are leading more businesses to reduce their innovation dependency on internal R&D. It is common practice to outsource R&D and purchase the rights to goods from smaller companies. Pharmaceutical firms are gradually entering into long-term drug development alliances with other pharmaceutical firms, universities and smaller biotech companies. Price, flexibility / scalability and exposure to new / different talent pools are the main drivers for businesses outsourcing diverse R&D functions. Companies traditionally outsourced the different functions to achieve a cost advantage, now more companies are outsourcing to get the best creativity and cooperation with their outsourcing partners. The old model was to outsource one part of the business cycle. The method was provided by outsourcers at less cost and with fair efficiency. R&D companies in life sciences today are looking at outsourcing as an innovation driver not only to bring drugs into the market quicker but also to get the information technology to make better decisions.

Advancement in Biotech Sector Driving the DDOS Market Growth

Over the last decade, a number of traditional in-house drug discovery activities have been rapidly outsourced to an increasingly competitive pharmaceutical industry that seeks to improve efficiency and reduce spending. This is due to advances in genomics and modern biotechnology, all of which have contributed to the explosion of new biological targets and new drug leads. The hit-to-candidate stage is eventually leading to a crucial bottleneck in the drug discovery process. In order to overcome this problem, the once secretive drug discovery process, such as lead identification and screening, is entrusted to drug discovery organizations specializing in areas such as chemistry services, biology services, lead optimisation as well as lead identification and screening. This push by pharmaceutical companies to gain a complete edge while remaining cost effective is the main driver drug discovery outsourcing. The main factor that the drug discovery outsourcing focuses on is the cost-saving benefits. Today’s companies are also looking at benefits and opportunities beyond cost savings. Companies are now outsourcing to obtain strategic benefits, such as access to new technologies or access to developing markets, quicker response time to help and benchmark internal initiatives, and ongoing process improvements, making them more competitive overall and growing globalization within the pharmaceutical industry.

What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery outsourcing market evolving?
• What is driving and restraining the drug discovery outsourcing market?
• How will each Drug Discovery Outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Drug Discovery Outsourcing submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Drug Discovery Outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Drug Discovery Outsourcing projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implication of Drug Discovery Outsourcing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
• Where is the drug discovery outsourcing market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
• Our 355-page report provides 122 tables and 150 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Drug Discovery Outsourcing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Segments Covered in the Report

Service Type
• Chemical Services
• Biology Services
• Lead Optimization
• Lead Identification & Screening
• Others

Molecule Type
• Large Molecule Drugs
• Small Molecule Drugs

Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
• Charles River Laboratories
• Curia Global, Inc.
• Dalton Pharma
• Domainex
• Eurofins
• Evotec AG
• Genscript
• Jubilant Biosys Ltd.
• Laboratory Corporation of America Holdings
• Pharmaron
• QIAGEN N.V.
• Selvita
• Sundia Meditech Co Ltd.
• Sygnature Discovery
• Syngene International
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Overall world revenue for Drug Discovery Outsourcing Market, 2022 to 2032 in terms of value the market will surpass US$9.8 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market, 2022 to 2032 Market report helps you?

In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Drug Discovery Outsourcing Market, 2022 to 2032 Market, with forecasts for Process, upstream, downstream, type company size each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 5 regional and 20 key national markets – See forecasts for the Drug Discovery Outsourcing Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Drug Discovery Outsourcing Market, 2022 to 2032 Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Product Design & Development Services Market Research Report by Services, Application, End-Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • July 2022
  • 236 pages

Product Design & Development Services Market Research Report by Services (Concept & Requirements Development, Design Verification, and Detailed Design & Process Development), Application, End-Use, Region ...

  • World
  • APAC
  • Medical Device
  • Marketing Research
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on